Abatacept Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project: An Extension Study
Phase of Trial: Phase IV
Latest Information Update: 29 Apr 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 24 Feb 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2018 as reported by the ClinicalTrials.gov record.
- 24 Feb 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2018 as reported by the ClinicalTrials.gov record..
- 19 Oct 2014 Planned number of patients changed from 10 to 240 as reported by ClinicalTrials.gov record.